IDiyas

For the Inventor, By the Inventor

Houston, TX, United States of America

Timothy Joseph McAfoos

USPTO Granted Patents = 15 

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 73(Granted Patents)


Location History:

  • Houston, TX (US) (2017 - 2021)
  • Pearland, TX (US) (2020 - 2024)

Company Filing History:

goldMedal15 out of 5,444 
 
University of Texas System
 patents

Years Active: 2017-2025

Loading Chart...
15 patents (USPTO):
1. 12186324 - Imidazopiperazine inhibitors of transcription activating proteins (2025-01-07),
2. 11958849 - GLS1 inhibitors for treating disease (2024-04-16),
3. 11725008 - Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases (2023-08-15),
4. 11370786 - GLS1 inhibitors for treating disease (2022-06-28),
5. 11173145 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase (2021-11-16),
6. 11058688 - Imidazopiperazine inhibitors of transcription activating proteins (2021-07-13),
7. 11046649 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase (2021-06-29),
8. 11028083 - Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases (2021-06-08),
9. 10899769 - Imidazopiperazinone inhibitors of transcription activating proteins (2021-01-26),
10. 10888554 - Salts of heterocyclic modulators of HIF activity for treatment of disease (2021-01-12),
11. 10766892 - GLS1 inhibitors for treating disease (2020-09-08),
12. 10363248 - Salts of heterocyclic modulators of HIF activity for treatment of disease (2019-07-30),
13. 10344025 - GLS1 inhibitors for treating disease (2019-07-09),
14. 9809588 - GLS1 inhibitors for treating disease (2017-11-07),
15. 9663504 - Salts of heterocyclic modulators of HIF activity for treatment of disease (2017-05-30),

Title: Innovations and Contributions of Timothy Joseph McAfoos

Introduction

Timothy Joseph McAfoos is a prominent inventor based in Houston, Texas. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target various diseases. With a total of 15 patents to his name, McAfoos has established himself as a key figure in innovative research.

Latest Patents

Among his latest patents, McAfoos has developed imidazopiperazine inhibitors of transcription activating proteins. This patent relates to heterocyclic compounds and methods that may be useful as inhibitors of transcription activating proteins such as CBP and P300. These compounds have potential applications in the treatment or prevention of proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases. Another notable patent involves GLS1 inhibitors for treating diseases. This patent discloses compounds and compositions that are useful in the treatment of GLS1 mediated diseases, such as cancer, and provides methods for inhibiting GLS1 activity in human or animal subjects.

Career Highlights

Timothy McAfoos is affiliated with the University of Texas System, where he conducts his research and development work. His career has been marked by a commitment to advancing medical science through innovative solutions. His work has garnered attention for its potential impact on treating complex diseases.

Collaborations

Throughout his career, McAfoos has collaborated with notable colleagues, including Philip Jones and Maria Emilia Di Francesco. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Timothy Joseph McAfoos is a distinguished inventor whose work in medicinal chemistry has led to significant advancements in the treatment of various diseases. His patents reflect a deep commitment to innovation and the betterment of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…